ENETS 2011 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update

First Page		Document Content
Date: 2013-01-30 10:42:18 Neuroendocrine tumor Gastrointestinal cancer Carcinoid Octreotide Neuroendocrinology Sunitinib TNM staging system Carcinoma Neuroendocrine cell Medicine Oncology Lung cancer		ENETS 2011 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update Add to Reading List Source URL: www.carcinoid.org Download Document from Source Website File Size: 86,57 KB Share Document on Facebook

	PDF Document DocID: 1xrdj - View Document
	ORIGINAL ARTICLE Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients Eugene A. Woltering, MD, FACS,* Vergilio A. Salvo, MD,* Thomas M. O_D DocID: 1rlNJ - View Document
	JOBNAME: pan 31#PAGE: 1 OUTPUT: Wednesday October 19 08:24:lww/panMPA200087 ORIGINAL ARTICLE Effect of Octreotide LAR Dose and Weight on Octreotide DocID: 1qMJM - View Document
	ORIGINAL ARTICLE Validation of Serum Versus Plasma Measurements of Chromogranin A Levels in Patients With Carcinoid Tumors Lack of Correlation Between Absolute Chromogranin A Levels and Symptom Frequency DocID: 1p1DF - View Document
	ORIGINAL ARTICLE Development of a Highly Sensitive and Specific Carboxy-Terminal Human Pancreastatin Assay to Monitor Neuroendocrine Tumor Behavior Thomas M. O’Dorisio, MD,* Siegfried R. Krutzik, PhD,Þ Eugene A. Wolt DocID: 1oIE2 - View Document